Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer

被引：58

作者：

Gower, Arjan ^{[1
]}

Wang, Yisong ^{[1
]}

Giaccone, Giuseppe ^{[1
]}

机构：

[1] Georgetown Univ, Washington, DC 20057 USA

来源：

JOURNAL OF MOLECULAR MEDICINE-JMM | 2014年 / 92卷 / 07期

关键词：

Non-small-cell lung cancer; Oncogenic drivers; TKIs; RTKs; Acquired resistance; GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITORS; MOLECULAR TESTING GUIDELINE; OF-AMERICAN-PATHOLOGISTS; EML4-ALK FUSION GENE; OPEN-LABEL; PHASE-III; ALK INHIBITOR; EGFR MUTATION; GEFITINIB RESISTANCE;

D O I：

10.1007/s00109-014-1165-y

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following molecular profiling has dramatically changed the way advanced adenocarcinoma is treated. However, tumor cells inevitably acquire resistance to such therapies, circumventing any sustained clinical benefit. As the genomic classification of lung cancer continues to evolve and as the mechanisms of acquired resistance to targeted therapies become elucidated and more improved target-specific drugs come into sight, the future will see more promising results from the clinic through the development of new therapeutic strategies to overcome, or prevent the development of, resistance for lung cancer patients.

引用

页码：697 / 707

页数：11

共 117 条

[11] MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib [J].

Bean, James ;

Brennan, Cameron ;

Shih, Jin-Yuan ;

Riely, Gregory ;

Viale, Agnes ;

Wang, Lu ;

Chitale, Dhananjay ;

Motoi, Noriko ;

Szoke, Janos ;

Broderick, Stephen ;

Balak, Marissa ;

Chang, Wen-Cheng ;

Yu, Chong-Jen ;

Gazdar, Adi ;

Pass, Harvey ;

Rusch, Valerie ;

Gerald, William ;

Huang, Shiu-Feng ;

Yang, Pan-Chyr ;

Miller, Vincent ;

Ladany, Marc ;

Yang, Chih-Hsin ;

Pao, William .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20932-20937

[12] Oncogenic RIT1 mutations in lung adenocarcinoma [J].

Berger, A. H. ;

Imielinski, M. ;

Duke, F. ;

Wala, J. ;

Kaplan, N. ;

Shi, G-X ;

Andres, D. A. ;

Meyerson, M. .

ONCOGENE, 2014, 33 (35) :4418-4423

[13] ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers [J].

Bergethon, Kristin ;

Shaw, Alice T. ;

Ou, Sai-Hong Ignatius ;

Katayama, Ryohei ;

Lovly, Christine M. ;

McDonald, Nerina T. ;

Massion, Pierre P. ;

Siwak-Tapp, Christina ;

Gonzalez, Adriana ;

Fang, Rong ;

Mark, Eugene J. ;

Batten, Julie M. ;

Chen, Haiquan ;

Wilner, Keith D. ;

Kwak, Eunice L. ;

Clark, Jeffrey W. ;

Carbone, David P. ;

Ji, Hongbin ;

Engelman, Jeffrey A. ;

Mino-Kenudson, Mari ;

Pao, William ;

Iafrate, A. John .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) :863-870

[14]

Bonanno L, 2014, ANTICANCER RES, V34, P493

[15] Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROSI gene rearrangement after treatment with crizotinib [J].

Bos, M. ;

Gardizi, M. ;

Schildhaus, H. U. ;

Heukamp, L. C. ;

Geist, T. ;

Kaminsky, B. ;

Zander, T. ;

Nogova, L. ;

Scheffler, M. ;

Dietlein, M. ;

Kobe, C. ;

Holstein, A. ;

Maintz, D. ;

Buettner, R. ;

Wolf, J. .

LUNG CANCER, 2013, 81 (01) :142-143

[16] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].

Brahmer, Julie R. ;

Tykodi, Scott S. ;

Chow, Laura Q. M. ;

Hwu, Wen-Jen ;

Topalian, Suzanne L. ;

Hwu, Patrick ;

Drake, Charles G. ;

Camacho, Luis H. ;

Kauh, John ;

Odunsi, Kunle ;

Pitot, Henry C. ;

Hamid, Omid ;

Bhatia, Shailender ;

Martins, Renato ;

Eaton, Keith ;

Chen, Shuming ;

Salay, Theresa M. ;

Alaparthy, Suresh ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Parker, Susan M. ;

Agrawal, Shruti ;

Goldberg, Stacie M. ;

Pardoll, Drew M. ;

Gupta, Ashok ;

Wigginton, Jon M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465

[17]

Camidge DR, 2013, J CLIN ONCOL, V31

[18] Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients [J].

Cappuzzo, Federico ;

Marchetti, Antonio ;

Skokan, Margaret ;

Rossi, Elisa ;

Gajapathy, Sujatha ;

Felicioni, Lara ;

del Grammastro, Maela ;

Sciarrotta, Maria Grazia ;

Buttitta, Fiamma ;

Incarbone, Matteo ;

Toschi, Luca ;

Finocchiaro, Giovanna ;

Destro, Annarita ;

Terracciano, Luigi ;

Roncalli, Massimo ;

Alloisio, Marco ;

Santoro, Armando ;

Varella-Garcia, Marileila .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) :1667-1674

[19] The Introduction of Systematic Genomic Testing for Patients with Non-Small-Cell Lung Cancer [J].

Cardarella, Stephanie ;

Ortiz, Taylor M. ;

Joshi, Victoria A. ;

Butaney, Mohit ;

Jackman, David M. ;

Kwiatkowski, David J. ;

Yeap, Beow Y. ;

Jaenne, Pasi A. ;

Lindeman, Neal I. ;

Johnson, Bruce E. .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (12) :1767-1774

[20] MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors [J].

Cepero, Virna ;

Sierra, J. Rafael ;

Corso, Simona ;

Ghiso, Elena ;

Casorzo, Laura ;

Perera, Tim ;

Comoglio, Paolo Maria ;

Giordano, Silvia .

CANCER RESEARCH, 2010, 70 (19) :7580-7590

← 1 2 3 4 5 6 7 8 9 10 →